Kraus F, Dacian S, Rudolph C, Rudolph W
Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München.
Herz. 1988 Apr;13(2):71-83.
Percutaneous transluminal valvuloplasty for mitral stenosis represents an alternative to surgical treatment. The reported increases in valve orifice area vary with values from 0.6 to 2.03 cm2 over a wide range. This study was undertaken to evaluate our own results and to determine if factors could be identified which may exert an influence on the outcome of the procedure. Additionally, to evaluate this new method of treatment, the pressure-flow relationship at rest and during exercise after valvuloplasty was compared with that observed after mitral valve commissurotomy or mitral valve replacement. In 25 patients with moderately-severe to severe mitral stenosis, mean age 56 +/- 11 years, mean valve orifice area 1.1 +/- 0.37 cm2, 52% with preexistent regurgitation, antegrade percutaneous, transvalvular valvuloplasty was carried out. Diagnostic catheterization was performed immediately prior to and after the procedure. Two concurrent groups of patients were analyzed for the purpose of comparison: 26 consecutive patients who underwent mitral valve commissurotomy with a comparable valve orifice area of 1.13 +/- 0.39 cm2 of whom 31% had a regurgitant component; and 37 consecutive patients who had valve replacement mostly with a Björk-Shiley prosthesis (M 29, 31, 33), mean age 52 +/- 8 years, comparable valve orifice area of 1.1 +/- 0.37 cm2 and a regurgitant component in 65%. Dilatation of the valve was carried out after transseptal catheterization with the use of an 8F Mullins sheath introducing a 7F balloon-tipped catheter (Critikon) via the left atrium, the left ventricle and into the descending aorta through which a 300 cm long 0.035" guidewire was advanced. By means of a retrieval catheter introduced via the femoral artery into the descending aorta, the guidewire was exteriorated via the femoral artery. After dilatation of the septum with a 9F dilatation catheter with a balloon of 8 mm diameter, a 10F or 12F dilatation catheter (Trefoil 3 X 12 mm or Bifoil 2 X 19 mm) (Schneider-Shiley) was advanced transseptally and the balloons positioned at the level of the mitral valve. The balloons were inflated with a pressure averaging 3.6 + 0.65 atmospheres (2-4.7 atm) and a mean duration of 27 +/- 8 s (16 to 45 s) on the average 3.9 +/- 1.6 times (1 to 9X) until disappearance or widening of the hour-glass waist of the balloon.(ABSTRACT TRUNCATED AT 400 WORDS)
经皮腔内二尖瓣成形术是外科治疗的一种替代方法。报道的瓣膜口面积增加范围很广,从0.6到2.03平方厘米不等。本研究旨在评估我们自己的结果,并确定是否能识别出可能影响该手术结果的因素。此外,为评估这种新的治疗方法,将二尖瓣成形术后静息和运动时的压力-流量关系与二尖瓣交界切开术或二尖瓣置换术后观察到的情况进行比较。对25例中重度至重度二尖瓣狭窄患者进行了顺行性经皮经瓣膜二尖瓣成形术,患者平均年龄56±11岁,平均瓣膜口面积1.1±0.37平方厘米,52%患者术前存在反流。手术前后立即进行诊断性心导管检查。为作比较,分析了两组同期患者:26例连续接受二尖瓣交界切开术的患者,其瓣膜口面积相当,为1.13±0.39平方厘米,其中31%有反流成分;37例连续接受瓣膜置换术的患者,大多使用Björk-Shiley人工瓣膜(M 29、31、33型),平均年龄52±8岁,瓣膜口面积相当,为1.1±0.37平方厘米,65%有反流成分。经房间隔导管插入术后,使用8F Mullins鞘管经左心房、左心室将7F球囊导管(Critikon公司)插入降主动脉,通过该导管推进一根300厘米长的0.035英寸导丝。通过经股动脉插入降主动脉的回收导管,将导丝经股动脉引出。用直径8毫米球囊的9F扩张导管扩张房间隔后,经房间隔推进10F或12F扩张导管(三叶形3×12毫米或双叶形2×19毫米)(Schneider-Shiley公司),将球囊置于二尖瓣水平。球囊平均以3.6 + 0.65个大气压(2 - 4.7个大气压)充气,平均持续时间27±8秒(16至45秒),平均充气3.9±1.6次(1至9次),直至球囊沙漏样腰部消失或变宽。(摘要截选至400字)